866-997-4948(US-Canada Toll Free)

Mice Model Market (by Model Type, by Specialty, by Services, and by Geography): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Published By :

Transparency

Published Date : Sep 2015

Category :

Biotechnology

No. of Pages : 155 Pages

 

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.2.1 Secondary Research
1.2.2 Primary Research
1.3 Market Segmentation
1.4 Assumptions and Stipulations

Chapter 2 Executive Summary
2.1 Global Mice Consumption, 2013
2.2 Market Snapshot: Global Mice Model Market (2014 and 2023E)
2.3 Global Mice Model Market, by Type, 2014 (USD Million)
2.4 Global Mice Model Market, by Application, 2014 (USD Million)
2.5 Global Mice Model Market, by Services, 2014 (USD Million)
2.6 Comparative Analysis: Global Mice Model Market Revenue, by Geography, 2014 and 2023E (Value %)

Chapter 3 Global Mice Model Market: Market Overview
3.1 Overview
3.1.1 Proportion of Mice as Compared to Total Animal Used in Research Globally (Value %), 2011
3.2 End-users of Mice Models
3.2.1 End-user Analysis of Mice Model Market (Value %), 2013
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Growing investment in biomedical research
3.3.1.2 Biomedical Research Growth Rate, 2007–2012, (%)
3.3.1.3 Growing number of advanced mice model would increase applicability and acceptability
3.3.1.4 Personalized in vivo analysis mice models would fuel demand for mice models in personalized medicine
3.3.2 Restraints
3.3.2.1 Rising concern about animal use across the globe would restrain the market
3.3.2.2 Development of alternative technologies
3.3.3 Opportunities
3.3.3.1 Countries in Asia offer immense growth opportunities in the mice model market
3.4 Event Impact Assessment: Mice Model Market
3.5 Market Attractiveness Analysis: Global Mice Model Market
3.5.1 Mice Model Market Analysis: The U.S. and China
3.5.2 Market Attractiveness Analysis: Global Mice Model Market, by Geography
3.5.3 Growth-Share Matrix Analysis: Global Mice Model Market, by Type
3.6 Competitive Landscape
3.6.1 Global Market Share Analysis, by Key Players, 2013 (Value %)
3.6.2 Global Market Share Analysis, by Key Players, 2014 (Value %)
3.6.3 Heat Map Analysis, by Key Geography, 2014 (Market Share)
3.6.4 Heat Map Analysis, by Key Geography, 2014 (Market Growth)

Chapter 4 Global Mice Model Market, by Type
4.1 Overview
4.1.1 Global Mice Model Market, by Type, 2013–2014 (USD Million)
4.1.2 Global Mice Model Market, by Model Type, 2015E–2023E (USD Million)
4.2 Transgenic Mice Model
4.2.1 Transgenic Mice Applications in Various Specialties (%)
4.2.2 Global Transgenic Mice Model Market, 2013–2023E (USD Million)
4.3 Hybrid/Congenic Mice Model
4.3.1 Global Hybrid/Congenic Mice Model Market, 2013–2023E (USD Million)
4.4 Knockout Mice Model
4.4.1 Knockout Mice Applications in Various Specialties, 2014 (%)
4.4.2 Global Knockout Mice Model Market, 2013–2023E (USD Million)
4.5 Carcinogen-induced and Spontaneous Mice Model
4.5.1 Global Carcinogen-induced and Spontaneous Mice Model Market, 2013–2023E (USD Million)
4.6 Outbred Mice Model
4.6.1 Global Outbred Mice Model Market, 2013–2023E (USD Million)
4.7 Inbred Mice Model
4.7.1.1 Inbred Mice Applications in various Specialties (%), 2014
4.7.1.2 Global Inbred Mice Model Market, 2013–2023E (USD Million)
4.8 Transplantation Mice Model
4.8.1 Global Transplantation Mice Model Market, 2013–2023E (USD Million)
4.9 Conditioned/Surgically Modified Mice Model
4.9.1 Global Conditioned/Surgically Modified Mice Model Market, 2013–2023E (USD Million)

Chapter 5 Global Mice Model Market, by Specialty
5.1 Overview
5.1.1 Global Mice Model Market, by Application, 2013–2014 (USD Million)
5.1.2 Global Mice Model Market, by Application, 2015E–2023E (USD Million)
5.2 Immunology
5.2.1 Global Immunology Mice Model Market, 2013–2023E (USD Million)
5.2.2 Number of Immunology Mice Models, by Major Companies
5.2.3 Immunology Mice Model Market Share, by Model Type, 2014
5.3 Central Nervous System (CNS)
5.3.1 Global CNS Mice Model Market, 2013–2023E (USD Million)
5.3.2 Number of CNS Mice Models, by Major Companies
5.3.3 CNS Mice Model Market Share, by Model Type, 2014
5.4 Oncology
5.4.1 Global Oncology Mice Model Market, 2013–2023E (USD Million)
5.4.2 Number of Oncology Mice Models, by Major Companies
5.4.3 Oncology Mice Model Market Share, by Model Type, 2014
5.5 Cardiovascular
5.5.1 Global Cardiovascular Mice Model Market, 2013–2023E (USD Million)
5.5.2 Number of Cardiovascular Mice Models, by Major Companies
5.5.3 Cardiovascular Mice Model Market Share, by Model Type, 2014
5.6 Diabetes
5.6.1 Global Diabetes Mice Model Market, 2013–2023E (USD Million)
5.6.2 Number of Diabetes Mice Models, by Major Companies
5.6.3 Diabetes Mice Model Market Share, by Model Type, 2014
5.7 Metabolism & Regulation
5.7.1 Global Metabolism & Regulation Mice Model Market, 2013–2023E (USD Million)
5.7.2 Metabolism & Regulation Mice Models Market Share, by Model Type, 2014

Chapter 6 Global Mice Model Market, by Services
6.1 Overview
6.1.1 Global Mice Model Market, by Services, 2013–2014 (USD Million)
6.1.2 Global Mice Model Market, by Services, 2015E–2023E (USD Million)
6.2 Breeding and Rederivation Services
6.2.1 Global Breeding and Rederivation Services Market, 2013–2023E (USD Million)
6.3 Cryopreservation and Cryorecovery Services
6.3.1 Global Cryopreservation and Cryorecovery Services Market, 2013–2023E (USD Million)
6.4 Quarantine Services
6.4.1 Global Quarantine Services Market, 2013–2023E (USD Million)
6.5 Genetic Testing Services
6.5.1 Global Genetic Testing Services Market, 2013–2023E (USD Million)
6.6 Model In-licensing Services
6.6.1 Global Model In-licensing Market, 2013–2023E (USD Million)
6.7 In vivo and In vitro Pharmacology Services
6.7.1 Global In vivo and In vitro Pharmacology Services Market, 2013–2023E (USD Million)
6.8 Genetically Engineered Model Services
6.8.1 Genetically Engineered Model Services
6.9 Other Services (Surgical and Line Rescue)
6.9.1 Global Other Services Market, 2013–2023E (USD Million)

Chapter 7 Global Mice Model Market, by Geography
7.1 Overview
7.1.1 Mice Model Market Share Index, 2014 (On Scale of 1 to 5)
7.1.2 Global Mice Model Market, Growth Index, 2015–2023 (On a Scale of 1 to 5)
7.1.3 Global Mice Model Market Revenue, by Geography, 2013–2023 (USD Million)
7.2 North America
7.2.1 North America Population, GDP, and Health care Expenditure, 2011–2013
7.2.2 North America Mice Model Market Revenue, 2013–2023E (USD Million
7.2.3 U.S.
7.2.3.1 U.S. Mice Model Market, 2013–2023E (USD Million)
7.2.4 Canada
7.2.4.1 Comparative Analysis: Proportion of Animals Used in Research in Canada, 2011 and 2012 (Value %)
7.2.4.2 Canada Mice Model Market, 2013–2023E (USD Million)
7.3 Europe
7.3.1 Europe Population, GDP, and Health care Expenditure, 2011–2013
7.3.2 Europe Mice Model Market Revenue, 2013–2023E (USD Million)
7.3.3 Germany
7.3.3.1 Germany Mice Model Market Revenue, 2013–2023E (USD Million)
7.3.4 U.K.
7.3.4.1 U.K. Mice Model Market Revenue, 2013–2023E (USD Million)
7.3.5 Rest of Europe
7.3.5.1 Rest of Europe Mice Model Market Revenue, 2013–2023E (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Population, GDP, and Healthcare Expenditure, 2011–2013
7.4.2 Asia Pacific Mice Model Market Revenue, 2013–2023E (USD Million)
7.4.3 Japan
7.4.3.1 Japan Mice Model Market, 2013–2023E (USD Million)
7.4.4 China
7.4.4.1 China Mice Model Market, 2013–2023E (USD Million)
7.4.5 Rest of Asia Pacific
7.4.5.1 Rest of Asia Pacific Mice Model Market, 2013–2023E (USD Million)
7.5 Latin America
7.5.1 Latin America Population, GDP, and Health care Expenditure, 2011 – 2013
7.5.2 Latin America Mice Model Market, 2013–2023E (USD Million)
7.5.3 Brazil
7.5.3.1 Brazil Mice Model Market, 2013–2023E (USD Million)
7.5.4 Mexico
7.5.4.1 Mexico Mice Model Market, 2013–2023E (USD Million)
7.5.5 Rest of Latin America
7.5.5.1 Rest of Latin America Mice Model Market, 2013–2023E (USD Million)
7.6 Middle East & North Africa (MENA)
7.6.1 MENA Mice Model Market, 2013–2023E (USD Million)
7.6.2 Saudi Arabia (KSA)
7.6.2.1 Saudi Arabia Mice Model Market, 2013–2023E (USD Million)
7.6.3 UAE
7.6.3.1 UAE Mice Model Market, 2013–2023E (USD Million)
7.6.4 Israel
7.6.4.1 Israel Mice Model Market, 2013–2023E (USD Million)
7.6.5 Rest of MENA
7.6.5.1 Rest of MENA Mice Model Market, 2013–2023E (USD Million)
7.7 Rest of the World (RoW)
7.7.1 RoW Population, GDP, and Health care Expenditure, 2011–2013
7.7.2 Rest of World Mice Model Market, 2013–2023E (USD Million)

Chapter 8 Recommendations
8.1 Focus on collaborations with contract research organizations or strengthening in-house research capabilities
8.2 Sustaining pricing pressures in a declining global economic scenario
8.3 Investing in emerging markets such as India, China, and Brazil

Chapter 9 Company Profiles
9.1 Charles River Laboratories International, Inc.
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Crescendo Biologics Limited
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 Deltagen, Inc.
9.3.1 Company Overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.3.5 Recent Developments
9.4 genOway S.A.
9.4.1 Company Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 Harbour Antibodies BV
9.5.1 Company Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Harlan Laboratories, Inc.
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 ImmunoGenes AG
9.7.1 Company Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.7.5 Recent Developments
9.8 SAGE Labs
9.8.1 Company Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 The Jackson Laboratory
9.9.1 Company Overview
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Taconic Biosciences, Inc.
9.10.1 Company Overview
9.10.2 Financial Overview
9.10.3 Product Portfolio
9.10.4 Business Strategies
9.10.5 Recent Developments
9.11 TransGenic, Inc.
9.11.1 Company Overview
9.11.2 Financial Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies
9.11.5 Recent Developments

List of Table

 

TABLE 1 Global Mice Consumption, 2013
TABLE 2 Market Snapshot: Global Mice Model Market (2014 and 2023E )
TABLE 3 Proportion of Mice as Compared to Total Animal Used in Research Globally (Value %), 2011
TABLE 4 End-user Analysis of Mice Model Market (Value %), 2013
TABLE 5 Global Mice Model Market, by Type, 2013–2014 (USD Million)
TABLE 6 Global Mice Model Market, by Model Type, 2015E–2023E (USD Million)
TABLE 7 Global Mice Model Market, by Application, 2013–2014 (USD Million)
TABLE 8 Global Mice Model Market, by Application, 2015E–2023E (USD Million)
TABLE 9 Global Mice Model Market, by Services, 2013–2014 (USD Million)
TABLE 10 Global Mice Model Market, by Services, 2015E–2023E (USD Million)
TABLE 11 Global Mice Model Market Revenue, by Geography, 2013–2023 (USD Million)
TABLE 12 North America Population, GDP, and Health care Expenditure, 2011–2013
TABLE 13 Europe Population, GDP, and Health care Expenditure, 2011–2013
TABLE 14 Europe Mice Model Market Revenue, 2013–2023E (USD Million)
TABLE 15 Asia Pacific Population, GDP, and Healthcare Expenditure, 2011–2013
TABLE 16 Asia Pacific Mice Model Market Revenue, 2013–2023E (USD Million)
TABLE 17 Latin America Population, GDP, and Health care Expenditure, 2011–2013
TABLE 18 Latin America Mice Model Market, 2013–2023E (USD Million)
TABLE 19 MENA Mice Model Market, 2013–2023E (USD Million)
TABLE 20 Row Population, GDP, and Health care Expenditure, 2011–2013

List of Chart

 

FIG. 1 Global Mice Model Market Segmentation
FIG. 2 Global Mice Model Market, By Type, 2014 (USD Million)
FIG. 3 Global Mice Model Market, By Application, 2014 (USD Million)
FIG. 4 Global Mice Model Market, By Services, 2014 (USD Million)
FIG. 5 Comparative Analysis: Global Mice Model Market Revenue, by Geography, 2014 and 2023E (Value %)
FIG. 6 Biomedical Research Growth Rate, 2007–2012, (%)
FIG. 7 Mice Model Market Analysis: The U.S. and China, 2014
FIG. 8 Market Attractiveness Analysis: Global Mice Model Market, by Geography
FIG. 9 Growth-Share Matrix Analysis: Global Mice Model Market, by Type
FIG. 10 Market Share Analysis: Global Mice Model Market, 2013 (Value %)
FIG. 11 Market Share Analysis: Global Mice Model Market, 2014 (Value %)
FIG. 12 Heat Map Analysis, by Key Geography, 2014 (Market Share)
FIG. 13 Heat Map Analysis, by Key Geography, 2014 (Market Growth)
FIG. 14 Transgenic Mice Applications in Various Specialties (%), 2014
FIG. 15 Transgenic Mice Model Market, 2013–2023E (USD Million)
FIG. 16 Hybrid/Congenic Mice Model Market, 2013–2023E (USD Million)
FIG. 17 Knockout Mice Applications in Various Specialties, 2014 (%)
FIG. 18 Knockout Mice Model Market, 2013–2023E (USD Million)
FIG. 19 Carcinogen-induced and Spontaneous Mice Model Market, 2013–2023E (USD Million)
FIG. 20 Outbred Mice Model Market, 2013–2023E (USD Million)
FIG. 21 Inbred Mice Applications in various Specialties (%), 2014
FIG. 22 Inbred Mice Model Market, 2013–2023E (USD Million)
FIG. 23 Transplantation Mice Model Market, 2013–2023E (USD Million)
FIG. 24 Conditioned/Surgically Modified Mice Model Market, 2013–2023E (USD Million)
FIG. 25 Immunology Mice Models Market, 2013–2023E (USD Million)
FIG. 26 Immunology Mice Models, by Major Companies
FIG. 27 Immunology Mice Model Market Share, by Model Type, 2014
FIG. 28 Immunology Mice Models Market, 2013–2023E (USD Million)
FIG. 29 Number of CNS Mice Models, by Major Companies
FIG. 30 Mice Model Market Share, by Model Type, 2014
FIG. 31 Oncology Mice Models Market, 2013–2023E (USD Million)
FIG. 32 Number of CNS Mice Models, by Major Companies
FIG. 33 Oncology Mice Model Market Share, by Model Type, 2014
FIG. 34 Cardiovascular Mice Models Market, 2013–2023E (USD Million)
FIG. 35 Number of CNS Mice Models, by Major Companies
FIG. 36 Cardiovascular Mice Model Market Share, by Model Type, 2014
FIG. 37 Diabetes Mice Models Market, 2013–2023E (USD Million)
FIG. 38 Number of Diabetes Mice Models, by Major Companies
FIG. 39 Diabetes Mice Model Market Share, by Model Type, 2014
FIG. 40 Metabolism & Regulation Mice Models Market, 2013–2023E (USD Million)
FIG. 41 Metabolism & Regulation Mice Models Market Share, by Model Type, 2014
FIG. 42 Global Breeding and Rederivation Services Market, 2013–2023E (USD Million)
FIG. 43 Global Cryopreservation and Cryorecovery Services Market, 2013–2023E (USD Million)
FIG. 44 Global Quarantine Services Market, 2013–2023E (USD Million)
FIG. 45 Global Genetic Testing Services Market, 2013–2023E (USD Million)
FIG. 46 Global Model In-licensing Market, 2013–2023E (USD Million)
FIG. 47 Global In vivo and In vitro Pharmacology Services Market, 2013–2023E (USD Million)
FIG. 48 Genetically Engineered Model Services
FIG. 49 Global Other Services Market, 2013–2023E (USD Million)
FIG. 50 Mice Model Market Share Index, 2014 (On Scale of 1 to 5)
FIG. 51 Global Mice Model Market, Growth Index, 2015–2023 (On a Scale of 1 to 5)
FIG. 52 U.S. Mice Model Market, 2013–2023E (USD Million)
FIG. 53 Comparative Analysis: Proportion of Animals Used in Research in Canada, 2011 and 2012 (Value %)
FIG. 54 Canada Mice Model Market, 2013–2023E (USD Million)
FIG. 55 Germany Mice Model Market Revenue, 2013–2023E (USD Million)
FIG. 56 U.K. Mice Model Market Revenue, 2013–2023E (USD Million)
FIG. 57 Rest of Europe Market Revenue, 2013–2023E (USD Million)
FIG. 58 Japan Mice Model Market, 2013–2023E (USD Million)
FIG. 59 China Mice Model Market, 2013–2023E (USD Million)
FIG. 60 Rest of Asia Pacific Mice Model Market, 2013–2023E (USD Million)
FIG. 61 Brazil Mice Model Market, 2013–2023E (USD Million)
FIG. 62 Mexico Mice Model Market, 2013–2023E (USD Million)
FIG. 63 Rest of Latin America Mice Model Market, 2013–2023E (USD Million)
FIG. 64 Saudi Arabia Mice Model Market, 2013 – 2023E (USD Million)
FIG. 65 UAE Mice Model Market, 2013–2023E (USD Million)
FIG. 66 Israel Mice Model Market, 2013–2023E (USD Million)
FIG. 67 Rest of MENA Mice Model Market, 2013–2023E (USD Million)
FIG. 68 Rest of World Mice Model Market, 2013–2023E (USD Million)
FIG. 69 Charles River Laboratories International, Inc.: Annual Revenue, 2012–2014 (USD Million)
FIG. 70 Charles River Laboratories International, Inc.: Business Segments
FIG. 71 Charles River Laboratories International, Inc.: Financials, 2012–2014
FIG. 72 Deltagen, Inc.: Annual Revenue, 2012–2014 (USD Million)
FIG. 73 Deltagen, Inc.: Financials, 2012–2014 (USD Million)
FIG. 74 genOway S.A.: Annual Revenue, 2012–2014 (USD Million)
FIG. 75 genOway S.A.: Financials, 2012–2014 (USD Million)
FIG. 76 The Jackson Laboratory: Annual Revenue, 2012–2014 (USD million)
FIG. 77 The Jackson Laboratory: Financials, 2012–2014 (USD million)
FIG. 78 TransGenic, Inc.: Annual Revenue, 2012–2014 (USD million)
FIG. 79 TransGenic, Inc.: Financials, 2012–2014 (USD million)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *